Clinical Trials Logo

Surgical Incision clinical trials

View clinical trials related to Surgical Incision.

Filter by:

NCT ID: NCT06228729 Not yet recruiting - Clinical trials for Endotracheal Intubation

Association Between EEG Changes and Hormonal Response to Tracheal Intubation and Surgical Stimulation

Start date: July 1, 2024
Phase:
Study type: Observational

This study aims to prospectively evaluate the relationship between changes in EEG and hormonal responses induced by endotracheal intubation and surgical incision following general anesthesia.

NCT ID: NCT06217081 Not yet recruiting - Surgical Wound Clinical Trials

3M™ Topical Tissue Adhesive Versus Commercially Available Tissue Adhesive for the Closure of Lacerations and Incisions

Lublin
Start date: April 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to generate safety and performance data for 3M™ Topical Tissue Adhesive. Enrolled subjects with qualifying trauma lacerations or surgical incisions will be randomized to receive 3M™ Topical Tissue Adhesive or Histoacryl® Blue Topical Skin Adhesive with follow-up visits at 10 days and 30 days after application of tissue adhesive.

NCT ID: NCT06202053 Recruiting - Surgical Incision Clinical Trials

An Observational Study on the Quality of Life After Precise Lung Resection Through the Periareolar Incision

Start date: September 28, 2023
Phase:
Study type: Observational [Patient Registry]

With the rapid development of video-assisted thoracoscopic technology, minimally invasive surgery has become the mainstream surgical approach and is widely known to the public. In addition to the pursuit of successful resection, patients seek an improvement in quality of life after surgery, which poses a challenge to surgeons. The surgical quality of uniportal video-assisted thoracoscopic surgery (VATS) is excellent. It has been shown to be superior to conventional VATS in many studies, especially with respect to the length of hospital stay and severity of pain/paresthesia. The rapid increase in the number of patients undergoing uniportal thoracoscopic surgery has led to the gradual widespread use of this technique. Therefore, how to further innovate this technology has become a direction of further research for surgeons. Here, we describe a rare uniportal thoracoscopic procedure through the perirareolar incision that has certain advantages over other uniportal thoracoscopic procedures.

NCT ID: NCT06047418 Completed - Surgical Incision Clinical Trials

Blepharoptosis in Indonesia: A 5-Year Multicenter Study on Characteristics and Surgical Evaluation

Start date: March 15, 2021
Phase:
Study type: Observational

The goal of this observational study is to learn about blepharoptosis cases in national referral hospitals in Indonesia. The main questions it aims to answer are: - How is the clinical characteristics, types, and surgical evaluations of blepharoptosis in this particular setting Participant who include in this study is a patient diagnosed with blepharoptosis cases and complete medical history from January 2016 to December 2020 across 10 tertiary hospitals in Indonesia from 5 provinces

NCT ID: NCT05989386 Recruiting - Clinical trials for Surgical Site Infection

Outcomes of High-volume Saline Irrigation VS Povidone-Iodine Solution Cleaning of IOWI in Preventing SSIs in Emergency Laparotomies

Start date: April 29, 2023
Phase: Phase 2/Phase 3
Study type: Interventional

The goal of this clinical trial is to compare the outcomes of High-volume saline irrigation vs Povidone-iodine solution cleaning of the intraoperative incision wound in preventing superficial surgical site infections in patients undergoing emergency laparotomies. The main question it aims to answer are: - Incidence of SSI after intervention - Length of hospital stay Participants will be randomly assigned to two groups receiving either of the two groups: Group A: 1000ml of IOWI with saline solution prior to incision closure Group B: The incisional wound will be closed conventionally without irrigation. Researchers will compare groups A( experimental group) and B (control group) to compare the incidence of superficial surgical site infections after intervention.

NCT ID: NCT05897723 Recruiting - Surgical Incision Clinical Trials

Fractional Radiofrequency for Reduction of Surgical Scar Formation

Start date: September 1, 2023
Phase: N/A
Study type: Interventional

Safety and Efficacy of Fractional Radiofrequency for the Reduction of Surgical Scar Formation

NCT ID: NCT05702827 Active, not recruiting - Clinical trials for Stress Urinary Incontinence

Use of a Dual-agent Local Analgesic (Bupivacaine-meloxicam) for Abdominal Incisions in Patients Undergoing Retropubic Mid-urethral Sling Surgery

Start date: January 23, 2023
Phase: Phase 3
Study type: Interventional

This study will compare the use of a dual-agent local analgesic (bupivacaine-meloxicam) for abdominal incisions in patients undergoing retropubic mid-urethral sling surgery to see if narcotic usage and pain are impacted.

NCT ID: NCT05687942 Not yet recruiting - Surgical Incision Clinical Trials

The REBUILD Trial: Closure of the Abdominal Wall

Start date: March 2023
Phase: N/A
Study type: Interventional

The main objective of this clinical trial is to demonstrate the safety and efficacy of REBUILD when used to support abdominal wall closure after laparotomy. The main question it aims to answer are whether the device when used to support suture in abdominal wall closure safely maintains apposition of the abdominis rectus muscles within a pre-defined distance. Participants will undergo standard of care laparotomy and the investigational device will be used to support the suture used to close the abdominal wall. Participants will have an MRI at 1-month after surgery to measure the distance between the abdominus rectus muscles.

NCT ID: NCT05618912 Completed - Clinical trials for Patient Satisfaction

Scar Appearance After Postoperative Hydrocolloid Dressing Versus Standard Petrolatum Ointment

Start date: October 17, 2022
Phase: N/A
Study type: Interventional

Patients will be randomized either to receive standard daily dressing or hydrocolloid dressing using a randomization generator. After closing the wound with the sutures,the scar will be covered by a hydrocolloid dressing, which will be left in place for 7 days(Experimental) or the standard dressing (Control) that will be covered with petrolatum jelly and bandaging during this time period, which has to be re-applied daily. Patients and dermatologic surgeons will then complete surveys 7 days, 30 days, and 90 days after surgery to evaluate the cosmetic appearance of these scars.

NCT ID: NCT05508945 Completed - Surgical Incision Clinical Trials

Silk Scaffold Surgical Incision Dressing

SSSID
Start date: August 23, 2022
Phase: Phase 1
Study type: Interventional

Interventional Study of the novel clinical application of SERI surgical silk scaffold affixed with dermaFLEX medical adhesive as a wound dressing, compared to two separate current standard of care for surgical incision closure devices: Prineo Dermabond and 3M Steri-Strip. Both components of the silk wound dressing prototype are FDA approved materials for other indications. This study seeks to gain insight of functionality of silk as a wound coverage material and determine variations of clinical outcomes in comparison to the synthetic mesh/cyanoacrylate device (Prineo Dermabond) and the nonwoven rayon/acrylate device (3M Steri-Strip) commonly implemented as a surgical wound dressing.